Study of isolated cubic GaN quantum dots by low-temperature cathodoluminescence

We report single dot spectroscopy of cubic GaN/AlN self-assembled quantum dots. Typical linewidths of the zero-phonon line between 2 and 8 meV are observed and interpreted in terms of charge fluctuations around a given quantum dot. The phonon sideband contribution in this emission, even at low temperature, reveals the importance of the acoustic phonon broadening mechanism which controls the exciton dephasing and may impose the real limits to the optical properties of GaN single QDs emission.     

中能区40Ar+197Au反应中轻粒子的发射时间测量

本文报道了25MeV/u ⁴⁰Ar+¹⁹⁷Au反应中粒子-粒子关联函数的实验结果.利用三体弹道模型从关联函数提取了轻粒子发射时间.轻粒子的平均发射时间随粒子能量而变化,从低能时的约300fm/c下降至高能时的约100fm/c.     

A semilinear non-classical pseudodifferential boundary value problem in the Sobolev spaces

We study the solvability of a semilinear non-classical pseudodifferential boundary value problem in the Sobolev spaces H_l,p,q, 1<p<∞, depending on a complex parameter q. To cite this article: Y.V. Egorov et al., C. R. Acad. Sci. Paris, Ser. I 337 (2003).     

Study on the New Fluorescence Enhancement System of Tb –N-(2 - Pyridinyl) Ketoacetamide-Et<Subscript>3</Subscript>N-Zn and its Application

A sensitive fluorescence enhancement system was developed for the determination of zinc (II). The fluorescence intensity of the Tb- N- (2 - Pyridinyl) ketoacetamide (PKA) system was greatly enhanced by the addition of triethylamine (Et₃N) and zinc nitrate in the methanol solution. The excitation and emission wavelengths were 329 nm and 546 nm, respectively. Under optimal conditions, the fluorescence intensities varied linearly with the concentration of Zn²⁺ in the range of 8.0×10⁻⁷−5.0×10⁻⁶ M with a detection limit of 9.9×10⁻⁸ M. The interferences of some substances were described. This method was applied to the determination of amounts of Zn²⁺ in soybean, rice, and wheat, respectively. The results showed that the proposed procedure is a high selective, simple, and rapid method to the determination of Zn²⁺ ion. The mechanism of fluorescence enhancement was also studied.     

Commercial Fe- or Co-containing carbon nanotubes as catalysts for NH3 decomposition

Fresh commercial carbon nanotubes (CNTs) containing residual Co or Fe nanoparticles are highly active for NH3 decomposition while the microstructure of CNTs remains unchanged. The catalysts are promising for elimination of NH3 from coal gasification stream and for production of H2 from NH3.     

Simultaneous arming and structure/activity studies of natural products employing O-H insertions: an expedient and versatile strategy for natural products-based chemical genetics

The identification of "druggable" targets is an immediate opportunity and challenge in the post-genomic era. Natural products are enduring tools for basic cellular studies and leads for identifying medically relevant protein targets. However, their use for these studies is often hampered by limited quantities and a lack of selective and mild monofunctionalization reactions. The development of selective methods that could simultaneously equip the natural product with a reactive group for subsequent conjugation to reporter tags and provide important structure-activity relationship (SAR) information, requiring only a knowledge of functional groups present in the natural product, could significantly decrease the time between bioactive natural product isolation and target identification. Herein, we report such a strategy that enables simultaneous arming and SAR studies of alcohol-containing natural products involving both chemo- and site-selective ("chemosite" selective) and site-nonselective O-H insertion reactions with rhodium carbenoids derived from alkynyl diazo acetates. This strategy was applied to a diverse set of natural products, and general guidelines for predicting chemosite selectivity were formulated. A subsequent Sharpless-Hüisgen [3 + 2] cycloaddition reaction with the appended alkyne allows for attachment of a variety of reporter tags. Using this strategy, we synthesized a novel FK506-biotin conjugate that enabled pull-down of the entire "immunosuppressive complex" including FKBP12, calcineurins A and B, and calmodulin. In addition, the potential for a chemoselective but site-nonselective process was shown with both gibberellic acid methyl ester and brefeldin A using only achiral rhodium catalysts.     

Structure-guided design of AMP mimics that inhibit fructose-1,6-bisphosphatase with high affinity and specificity

AMP binding sites are commonly used by nature for allosteric regulation of enzymes controlling the production and metabolism of carbohydrates and lipids. Since many of these enzymes represent potential drug targets for metabolic diseases, efforts were initiated to discover AMP mimics that bind to AMP-binding sites with high affinity and high enzyme specificity. Herein we report the structure-guided design of potent fructose 1,6-bisphosphatase (FBPase) inhibitors that interact with the AMP binding site on FBPase despite their structural dissimilarity to AMP. Molecular modeling, free-energy perturbation calculations, X-ray crystallography, and enzyme kinetic data guided our redesign of AMP, which began by replacing the 5'-phosphate with a phosphonic acid attached to C8 of the adenine base via a 3-atom spacer. Additional binding affinity was gained by replacing the ribose with an alkyl group that formed van der Waals interactions with a hydrophobic region within the AMP binding site and by replacing the purine nitrogens N1 and N3 with carbons to minimize desolvation energy expenditures. The resulting benzimidazole phosphonic acid, 16, inhibited human FBPase (IC50 = 90 nM) 11-fold more potently than AMP and exhibited high specificity for the AMP binding site on FBPase. 16 also inhibited FBPase in primary rat hepatocytes and correspondingly resulted in concentration-dependent inhibition of the gluconeogenesis pathway. Accordingly, these results suggest that the AMP site of FBPase may represent a potential drug target for reducing the excessive glucose produced by the gluconeogenesis pathway in patients with type 2 diabetes.